Search Results - "European review for medical and pharmacological sciences"
-
1
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines
Published in European review for medical and pharmacological sciences (01-02-2021)“…The "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)" disease has caused a worldwide challenging and threatening pandemic (COVID-19), with huge…”
Get more information
Journal Article -
2
Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV
Published in European review for medical and pharmacological sciences (01-02-2020)“…Human infections with zoonotic coronavirus contain emerging and reemerging pathogenic characteristics which have raised great public health concern. This study…”
Get more information
Journal Article -
3
Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience
Published in European review for medical and pharmacological sciences (01-04-2020)“…SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-related pneumonia, referred to as COVID-19 (Coronavirus Disease 19), is a public health emergency…”
Get more information
Journal Article -
4
COVID-19 (Novel Coronavirus 2019) - recent trends
Published in European review for medical and pharmacological sciences (01-02-2020)“…The World Health Organization (WHO) has issued a warning that, although the 2019 novel coronavirus (COVID-19) from Wuhan City (China), is not pandemic, it…”
Get more information
Journal Article -
5
Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics
Published in European review for medical and pharmacological sciences (01-12-2021)“…The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has created a challenging and threatening situation worldwide. The SARS-CoV-2 embodies diverse…”
Get more information
Journal Article -
6
Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review
Published in European review for medical and pharmacological sciences (01-12-2021)“…Recently a new variant of SARS-CoV-2 was reported from South Africa. World Health Organization (WHO) named this mutant as a variant of concern - Omicron…”
Get more information
Journal Article -
7
Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha
Published in European review for medical and pharmacological sciences (01-03-2020)“…In December 2019, a new type of coronavirus-infected pneumonia broke out in Wuhan and spread rapidly to other parts of the country. The purpose of this study…”
Get more information
Journal Article -
8
SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options
Published in European review for medical and pharmacological sciences (01-04-2020)“…SARS-CoV-2 is responsible for the outbreak of severe respiratory illness (COVID-19) in Wuhan City, China and is now spreading rapidly throughout the world. The…”
Get more information
Journal Article -
9
Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak
Published in European review for medical and pharmacological sciences (01-03-2020)“…An outbreak of a novel coronavirus disease-19 (nCoV-19) infection began in December 2019 in Wuhan, China, and now involved the whole word. Several health…”
Get more information
Journal Article -
10
Clinical efficacy of lopinavir/ritonavir in the treatment of Coronavirus disease 2019
Published in European review for medical and pharmacological sciences (01-03-2020)“…The Coronavirus disease 2019 (COVID-19) which outbroke in December 2019 is highly contagious with a low cure rate. In view of this, there is an urgent need to…”
Get more information
Journal Article -
11
Inflammation, apoptosis and autophagy as critical players in vascular dementia
Published in European review for medical and pharmacological sciences (01-09-2020)“…Vascular dementia is the second-most cause of dementia, characterized by cerebral infarcts, white matter lesions, myelin loss and often amyloid angiopathy…”
Get more information
Journal Article -
12
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
Published in European review for medical and pharmacological sciences (01-04-2020)“…The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also called COVID-19, has caused a pandemic which has swiftly involved the entire world…”
Get more information
Journal Article -
13
The role of diet on gut microbiota composition
Published in European review for medical and pharmacological sciences (01-11-2016)“…Gut microbiota is characterized by an inter-individual variability due to genetic and environmental factors. Among the environmental ones, dietary habits play…”
Get more information
Journal Article -
14
Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143
Published in European review for medical and pharmacological sciences (01-09-2015)“…Long non coding RNA (LncRNA) urothelial carcinoma-associated 1 (UCA1) is an oncogene in breast cancer. However, the detailed mechanism has not been fully…”
Get more information
Journal Article -
15
LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway
Published in European review for medical and pharmacological sciences (01-01-2017)“…Atherosclerosis is one of the leading causes of mortality in the world, which is a multistep cardiovascular disease promoted by several of risk factors…”
Get more information
Journal Article -
16
Coronavirus disease 2019: a bibliometric analysis and review
Published in European review for medical and pharmacological sciences (01-03-2020)“…On December 8, 2019, many cases of pneumonia with unknown etiology were first reported in Wuhan, China, subsequently identified as a novel coronavirus…”
Get more information
Journal Article -
17
Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis
Published in European review for medical and pharmacological sciences (01-03-2022)“…The outbreak of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in the death of up to 5…”
Get more information
Journal Article -
18
LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway
Published in European review for medical and pharmacological sciences (01-07-2017)“…The metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a long non-coding RNA (lncRNA) that plays a key role in the malignant phenotype of…”
Get more information
Journal Article -
19
Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3
Published in European review for medical and pharmacological sciences (01-03-2017)“…Angiogenesis is a key event in the progression of gliomas, and emerging evidence suggests that exosomes are signaling extracellular organelles that modulate…”
Get more information
Journal Article -
20
Obstructive Sleep Apnea, oxidative stress, inflammation and endothelial dysfunction-An overview of predictive laboratory biomarkers
Published in European review for medical and pharmacological sciences (01-06-2020)“…Obstructive Sleep Apnea (OSA) represents an emerging public health concern with great impact on cardiovascular state. Oxidative stress (OS), inflammation and…”
Get more information
Journal Article